Results 61 to 70 of about 199,904 (212)

Epidermolysis bullosa: A rare challenge for peritoneal dialysis nurses [PDF]

open access: yes, 2013
Epidermolysis bullosa is a genetic skin disorder characterised by blister formation in response to minimal trauma or friction. Our renal service was required to provide peritoneal dialysis (PD) for a young lady suffering from this rare disease and this
Cuesta, C, Blow, T, Tranter, SA
core  

Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study [PDF]

open access: yes
Early Access[EN] Background In 2020, the coronavirus disease 2019 (COVID-19) pandemic caused disruptions in kidney replacement therapy (KRT) services worldwide.
Jager, Kitty J.   +15 more
core   +1 more source

The cost of implementing UK guidelines for the management of chronic kidney disease [PDF]

open access: yes, 2007
Background. Chronic kidney disease (CKD) is a major public health problem. In the UK, guidelines have been developed to facilitate case identification and management.
B. Klebe   +35 more
core   +1 more source

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation

open access: yesFrontiers in Immunology, 2019
IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. The disease generally runs an indolent course but may lead to ESRD in 20–30% of patients in 20 years or more after diagnosis.
Gabriella Moroni   +5 more
doaj   +1 more source

End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing [PDF]

open access: yes
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care.
Margaret A. Eichleay   +3 more
core  

Anaemia management in non-dialysis chronic kidney disease (CKD) patients : a multicentre prospective study in renal clinics [PDF]

open access: yes, 2013
BACKGROUND: Knowledge on anaemia management in non-dialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement.
L. De Nicola   +27 more
core   +1 more source

Super high-flux dialyzers improve survival in patients on hemodialysis: a cohort study of the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry

open access: yesRenal Replacement Therapy
Background In Japan dialyzers are classified as type I, II, III, IV, or V on the basis of the β 2-microglobulin clearance. In 2023, Type V dialyzers were defined as super high-flux membrane dialyzers.
Masanori Abe   +5 more
doaj   +1 more source

The Multidisciplinary Approach to Renal Denervation: Current Evidences and Open Questions [PDF]

open access: yesEuropean Medical Journal Nephrology, 2014
Renal denervation (RD) is a new clinical procedure which aims to treat resistant hypertensive patients. As with every new technology introduced into the clinical setting, many aspects were not explored sufficiently in order to be implemented into routine
Sara Samoni   +10 more
doaj  

Reversible Fluindione-Induced Chronic Interstitial Nephritis

open access: yesCase Reports in Nephrology, 2016
Fluindione is well known to induce acute drug-induced interstitial nephritis (IN). Most cases occurred soon after the onset of treatment. We report a unique case of severe subacute fluindione-induced IN diagnosed 2 years after the treatment was begun ...
Thomas Crepin   +5 more
doaj   +1 more source

Effects of hemodialysis on circulating adrenomedullin concentrations in patients with end-stage renal disease [PDF]

open access: yes, 1998
To characterize the determinants of circulating levels of adrenomedullin (AM), the plasma levels of this peptide were measured in 58 patients with end-stage renal disease on hemodialysis, Predialysis plasma levels of AM were more than twice as high in ...
Schlosshauer, M.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy